Association of Triple Therapy with Improvement in Cholesterol Profiles over Two Year Follow-up in the TEAR Trial

OBJECTIVE: To evaluate long term changes in cholesterol levels in early rheumatoid arthritis (RA) patients randomized to initiate methotrexate (MTX) monotherapy, methotrexate + etanercept (MTX+ETA), or triple therapy (TT) [MTX + sulfasalazine (SSZ) + hydroxychloroquine (HCQ)] in the Treatment of Ear...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Arthritis Rheumatol
Autores principales: Charles-Schoeman, Christina, Wang, Xiaoyan, Lee, Yuen Yin, Shahbazian, Ani, Navarro-Millán, Iris, Yang, Shuo, Chen, Lang, Cofield, Stacey S, Moreland, Larry W, O’Dell, James, Bathon, Joan, Paulus, Harold, Bridges, S. Louis, Curtis, Jeffrey R
Formato: Artigo
Lenguaje:Inglês
Publicado: 2016
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4774543/
https://ncbi.nlm.nih.gov/pubmed/26606398
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/art.39502
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares